Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    thumbnail
    Making sense of the rapidly changing biosimilars landscape

    Strategies for adapting and achieving optimal market access

    thumbnail
    Building a comparative evidence base using network meta-analysis

    Methods, implementation and reporting

    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    Bioanalytical laboratory documentation
    Panel discussion: Flow cytometry in bioanalysis

    26 March 2026. Register today.

    thumbnail
    ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. News & Events
  3. Social media

Social media

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Showing 613 - 624 of 1038 results for "*"

ICON Plc facebook post
ICON Plc logo
ICON Plc

Meet us at AASLD, booth #1041 to learn how our deep expertise in imaging-based hepatic biomarkers and global operational support help sponsors optimise trial design and accelerate the delivery of MASH treatments to patie...

30 Oct
3
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Meet us at AASLD, booth \#1041 to learn how our deep expertise in imaging-based hepatic biomarkers and global operational support help sponsors optimise trial design and accelerate the delivery of MASH treatments to pati...

30 Oct
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

The FDA and other health authorities like the EMA require a well-defined and consistent drug development process and life cycle management plan. CMC is a critical and a ‘first step’ component in the creation of a develop...

30 Oct
2
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Upstream and downstream process, structural characterisation, functional characterisation and processes are all major CMC related steps that need to be considered by emerging and biotech companies early in their developm...

30 Oct
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

USP compounding may be fast — but is it costing you quality, compliance, and insight? Join our webinar to learn why GMP is the smarter choice for early phase trials. During this session we will discuss: • The differences...

30 Oct
3
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

USP compounding may be fast — but is it costing you quality, compliance, and insight? Join our webinar to learn why GMP is the smarter choice for early phase trials. During this session we will discuss: • The differences...

30 Oct
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

The incidence of chronic disease across APAC is rising. Biosimilars, with their potential to deliver high-quality treatment at lower costs, are well-positioned to meet this need. However, barriers to adoption, both from ...

30 Oct
6
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

The Asia-Pacific (APAC) region is quickly becoming a key player in the global biosimilars market. Additionally, as the region’s incidence of chronic disease rises, this is driving demand for more cost-effective treatment...

30 Oct
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Pediatric clinical trials have different processes, risks and challenges than adult trials. Identifying those differences is critical but can be difficult, especially if resources are limited. In our on-demand webinar, ...

30 Oct
2
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Clinical development processes for pediatric trials differ from adult trials. Watch our on-demand webinar to learn about regulatory strategies and tools needed to ensure pediatric access to medical treatment and an inter...

30 Oct
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Know where every sample is, every step of the way. LabView360 provides real-time visibility, reducing manual errors, and accelerating results. With an intuitive mobile-responsive app, sites can scan barcodes, streamline...

30 Oct
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Know where every sample is, every step of the way. LabView360 provides real-time visibility, reducing manual errors, and accelerating results. With an intuitive mobile-responsive app, sites can scan barcodes, streamline...

30 Oct
4
View post
View webpage
  • Previous
  • 1
  • …
  • 51
  • 52
  • 53
  • …
  • 87
  • Next
Filter by:

Filter by:

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence